Insider Transactions in Q4 2020 at Five Prime Therapeutics, Inc. (FPRX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2020
|
Helen Louise Collins EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,583
-11.93%
|
$185,328
$16.14 P/Share
|
|
Dec 11
2020
|
Helen Louise Collins EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+18.47%
|
-
|
|
Dec 11
2020
|
David V Smith Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,504
-12.84%
|
$184,064
$16.14 P/Share
|
|
Dec 11
2020
|
David V Smith Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+19.72%
|
-
|
|
Dec 11
2020
|
Francis Willard Sarena Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,583
-8.39%
|
$185,328
$16.14 P/Share
|
|
Dec 11
2020
|
Francis Willard Sarena Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+13.75%
|
-
|
|
Nov 26
2020
|
David V Smith Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,920
-9.29%
|
$124,560
$18.45 P/Share
|
|
Nov 11
2020
|
William R Ringo Director |
SELL
Open market or private sale
|
Direct |
78,959
-78.17%
|
$1,737,098
$22.5 P/Share
|
|
Nov 11
2020
|
William R Ringo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
78,959
+43.81%
|
$157,918
$2.51 P/Share
|
|
Nov 11
2020
|
Helen Louise Collins EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,039
-12.81%
|
$198,702
$18.0 P/Share
|
|
Nov 11
2020
|
Helen Louise Collins EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+20.34%
|
-
|
|
Nov 11
2020
|
David V Smith Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,908
-12.77%
|
$196,344
$18.0 P/Share
|
|
Nov 11
2020
|
David V Smith Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+20.49%
|
-
|
|
Nov 11
2020
|
Francis Willard Sarena Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,001
-8.66%
|
$198,018
$18.0 P/Share
|
|
Nov 11
2020
|
Francis Willard Sarena Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+14.76%
|
-
|
|
Nov 11
2020
|
Bvf Partners L P |
SELL
Open market or private sale
|
Direct |
7,393,340
-85.8%
|
$147,866,800
$20.19 P/Share
|
|
Nov 06
2020
|
Bvf Partners L P |
BUY
Open market or private purchase
|
Direct |
30,000
+0.36%
|
$120,000
$4.98 P/Share
|
|
Nov 04
2020
|
Bvf Partners L P |
BUY
Open market or private purchase
|
Direct |
416,562
+3.97%
|
$1,666,248
$4.88 P/Share
|
|
Oct 06
2020
|
Bvf Partners L P |
BUY
Open market or private purchase
|
Direct |
345,241
+4.16%
|
$1,726,205
$5.04 P/Share
|